These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 16010093

  • 1. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E, Laçin M, Asal K, Ceylan A, Köybaşioğlu A, Ileri F, Uslu SS.
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [Abstract] [Full Text] [Related]

  • 2. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
    Wollenberg B, Jan V, Schmit UM, Hofmann K, Stieber P, Fateh-Moghadam A.
    Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
    [Abstract] [Full Text] [Related]

  • 3. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P.
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [Abstract] [Full Text] [Related]

  • 4. CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA.
    Molina R, Filella X, Augé JM, Bosch E, Torne A, Pahisa J, Lejarcegui JA, Rovirosa A, Mellado B, Ordi J, Biete A.
    Anticancer Res; 2005 Dec; 25(3A):1765-71. PubMed ID: 16033097
    [Abstract] [Full Text] [Related]

  • 5. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S, Kimura H, Iwai N, Shima M, Ando M, Kuriyama T.
    Anticancer Res; 2001 Dec; 21(4B):3085-92. PubMed ID: 11712815
    [Abstract] [Full Text] [Related]

  • 6. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma.
    Yamamoto K, Oka M, Hayashi H, Tangoku A, Gondo T, Suzuki T.
    Cancer; 1997 May 01; 79(9):1647-55. PubMed ID: 9128978
    [Abstract] [Full Text] [Related]

  • 7. Clinical effectiveness of tumor markers in squamous cell carcinoma of the larynx.
    Eleftheriadou A, Chalastras T, Ferekidou E, Kyriou L, Yiotakis I, Pappas Z, Ferekidis E, Kandiloros D.
    Anticancer Res; 2006 May 01; 26(3B):2493-7. PubMed ID: 16821638
    [Abstract] [Full Text] [Related]

  • 8. Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma.
    Ayude D, Gacio G, Páez de la Cadena M, Pallas E, Martínez-Zorzano VS, de Carlos A, Rodríguez-Berrocal FJ.
    Oncol Rep; 2003 May 01; 10(5):1345-50. PubMed ID: 12883705
    [Abstract] [Full Text] [Related]

  • 9. Tumor markers and lymphatic metastasis in head and neck cancer patients.
    Büntzel J, Hornig A, Glatzel M, Micke O, Bruns F, Schäfer U, Fröhlich D.
    Anticancer Res; 2005 May 01; 25(3A):1539-42. PubMed ID: 16033056
    [Abstract] [Full Text] [Related]

  • 10. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C, Sliutz G, Mustafa G, Bieglmayr C, Koelbl H, Reinthaller A, Gitsch G.
    Gynecol Oncol; 1995 Mar 01; 56(3):402-5. PubMed ID: 7535720
    [Abstract] [Full Text] [Related]

  • 11. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
    Arlt A, Luckhaupt H, Hildmann H.
    Laryngorhinootologie; 2000 Apr 01; 79(4):207-12. PubMed ID: 10838684
    [Abstract] [Full Text] [Related]

  • 12. [Study of Cyfra 21-1 as a new tumor marker for the diagnosis of epidermoid carcinoma of the head and neck].
    González Sánchez E, López-Ríos Velasco J, Calvo Boizas E, García-Talavera Fernández JR, Martín Ro-dríguez M, Muñoz Herrera A, Del Cañizo Alvarez A.
    Acta Otorrinolaringol Esp; 1999 Mar 01; 50(2):85-9. PubMed ID: 10217679
    [Abstract] [Full Text] [Related]

  • 13. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J, Peltri G, Bitterlich N, Neu K, Velcovsky HG, Morr H, Katz N, Eigenbrodt E.
    Anticancer Res; 2003 Mar 01; 23(2A):899-906. PubMed ID: 12820320
    [Abstract] [Full Text] [Related]

  • 14. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E.
    Anticancer Res; 1999 Mar 01; 19(4C):3613-8. PubMed ID: 10629660
    [Abstract] [Full Text] [Related]

  • 15. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P.
    Anticancer Res; 1997 Mar 01; 17(3C):2329-34. PubMed ID: 9245246
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers.
    Shimada Y, Watanabe G, Kawamura J, Soma T, Okabe M, Ito T, Inoue H, Kondo M, Mori Y, Tanaka E, Imamura M.
    Oncology; 2005 Mar 01; 68(2-3):285-92. PubMed ID: 16015046
    [Abstract] [Full Text] [Related]

  • 17. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
    Wakatsuki M, Suzuki Y, Nakamoto S, Ohno T, Ishikawa H, Kiyohara H, Kiyozuka M, Shirai K, Nakayama Y, Nakano T.
    J Gastroenterol Hepatol; 2007 May 01; 22(5):715-9. PubMed ID: 17444861
    [Abstract] [Full Text] [Related]

  • 18. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R, Auge JM, Filella X, Viñolas N, Alicarte J, Domingo JM, Ballesta AM.
    Anticancer Res; 2005 May 01; 25(3A):1773-8. PubMed ID: 16033098
    [Abstract] [Full Text] [Related]

  • 19. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma.
    Nagler RM, Barak M, Peled M, Ben-Aryeh H, Filatov M, Laufer D.
    Cancer; 1999 Mar 01; 85(5):1018-25. PubMed ID: 10091783
    [Abstract] [Full Text] [Related]

  • 20. Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma.
    Deng YF, Chen P, Lin YZ, Le JZ, Wu XL, Yu MQ, Zhuang PY, Gao MH.
    J Laryngol Otol; 2003 Mar 01; 117(3):190-4. PubMed ID: 12648374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.